Summary.-Thromboplastic and fibrinolytic activities of 14 lines of cultured human cancer cells were estimated by modified Astrup's methods. High tissue thromboplastic activity was found in one line of urinary-bladder cancer, 2 lines of gastric cancer and one line of lung cancer, but no activity was found in 6 lines of lung cancer. High fibrinolytic activity was noted in one line of gastric cancer and 2 lines of lung cancer, but no activity was seen in 6 lines of lung cancer and one line of gastric cancer. No plasmin activity was found. The tumour cell lines could be classified into 3 groups on the basis of the 2 activities. Cancer cell lines could also be classified into 2 groups: with high or low release of thromboplastin into culture media. Fibrinolytic activity was found in the culture media of all cell lines with high fibrinolytic activity. Fibrinolytic activity, but not thromboplastic activity, seemed to be influenced by the constituents of culture media. No definite correlation was found between the 2 activities and the histological types of the parent tumours of the cultured cells.
THROMBOPLASTIC and fibrinolytic activities of tumour cells themselves are considered to be important factors in the following events: first, thrombosis (Rohner et at., 1966) and disseminated intravascular coagulation syndrome (Peck & Reiquam, 1973) in cancer patients; second, local growth of the tumour at the primary site (Peterson, 1968) ; third, haematogenous metastases in the form of lodgement and extravasation of arrested tumour cells in remote organs (Tanaka et al., 1977) .
Since the reports by Unkeless et al. (1973) and Ossowski et al. (1973) , the correlation between oncogenic transformation of cells and plasminogen activator production in established cell lines has been watched with keen interest. Such a plasminogen activator secreted by cultured human cancer cell lines has also been investigated in terms of purification and characterization of its true nature (Wu et al., 1977) . Thus, much information has now been accumulated on the role of coagulation and fibrinolysis systems of cancer cells in the field of oncology. But the systematic evaluation of thromboplastic and fibrinolytic activities of human cancer cells themselves has not been made.
In the present study, we estimated these activities of 14 lines of human cancer cells in vitro, from which thromboplastic material and plasminogen activator originating from the stromal elements of the tumour and/or from the blood are excluded.
MATERIALS AND METHODS
Cancer cells.-The cancer cell lines used in this experiment were composed of one line of urinary bladder cancer (KU 1), one line ofrenal pelvic cancer (KP 1), 3 lines of gastric cancer (MKN 1, MKN 28, MKN 45) and 9 lines of lung cancer (QG 56, QG 90, PC 1, PC 5, PC 7, PC 8, PC 9, PC 10, PC 12 (Kuga et al., 1975; Yasumoto et al., 1976; Hojo, 1976 128-8 ± 4-2 100 92-0± 6 Astrup (1965 Astrup ( , 1970 shown in Fig. 4 . Sonication was performed with sonifier, Model W185 E (Branson Sonic Power Co., U.S.A.). The total protein concentration of each lysate was determined by the method of Lowry et al. (1951) and shown in Table II .
Thromboplastic activity was assayed at 3700 in a system consisting of 0-2 ml of 0-03 % CaCl2. The solutions were preheated for 3 min before the experiment. The activity was recorded as plasma recalcification time (PRT).
In order to determine whether coagulation mainly depended upon extrinsic or intrinsic system, 3 groups were made. First, all the lysates were subjected to an assay system using standard human plasma; second, 9 cell lines which showed high-to-moderate activity in the first assay system were also assayed in a system with Factor VII or Factor IX deficient human plasma instead of standard human plasma.
Specimens of human brain taken from 4 cadavers aged 64 to 74 years were also treated as a control and used to assay the thromboplastic activity using the same method as for the cultured cells.
For the assay of fibrinolytic activity, 30 ,ul aliquots obtained by the method in Fig. 4 were applied to the standard and plasminogenfree fibrin plates, which were then incubated at 370C for 18 h. Fibrinolytic activity was compared with standard urokinase (Mochida Pharmaceutical Co., Japan) and expressed in International Units (i.u./ml) of urokinase. Furthermore, plasminogen-free fibrinogen was prepared from human fibrinogen (The Green Cross Corp., Japan) by affinity chromatography on lysine-Sepharose (Daiichi Pure Chemicals Co., Japan) by the method of Deutsch & Mertz (1970) .
Used and unused culture media were also examined for thromboplastic and fibrinolytic activities, using methods similar to those shown in Fig. 4 
RESULTS
Thromboplastic activity Plasma recalcification time in seconds (PRT) was recorded on 10 samples of each tumour cell line. Average values and standard deviations are shown in Table III . A varied degree of thromboplastic activity was found. Some cell lines of gastric cancer and Urinary bladder cancer showed high activity, whereas most of lung cancer cell lines had low activity. In terms of thromboplastic activity, the cancer cell lines used in this experiment could be divided into 3 arbitrary groups, as shown in Table IV . Every cell line showed high activity when using Factor IX-deficient plasma but lower activity in a system using Factor VII-deficient plasma than with standard human plasma. This result implies that the thromboplastic activity of tumour cells is due to their own tissue thromboplastin. Table III , but the media from cell lines with low thromboplastic activity showed none. In one gastric cancer (MKN 28), however, the cells showed high activity, while the culture medium had extremely low activity. Fresh culture medium showed no thromboplastic activity.
Urinary-bladder cancer (KU 1) showed similarly high activity, whether cultivated (Table VI) . Cancer cell lines were divided into 3 arbitrary groups as shown in Table VII . Gastric cancer (MKN 1) and 2 lines of lung cancer (QG 56, PC 9) showed high fibrinolytic activity (>1 i.u./ml of urokinase). Urinary bladder cancer (KU 11), renal pelvic cancer (KP 1), one gastric cancer (MKN 28) and one lung cancer (QG 90) (Table VI) .
Culture media from 3 lung cancer cultures (QG 56, QG 90, PC 9) and gastric cancer (MKN 1), whose cells showed fibrinolytic activity, revealed slight activity (Table VI) , but unused culture medium showed none.
No plasmin activity was found in any cancer cell lines on plasminogen-free plates.
DISCUSSION
It is well known that thromboplastin is contained in fibroblasts (Zacharski & McIntyre, 1973) amnion cells (Maynard et al., 1976) leucocytes (Kochiba et al., 1972) , tumour cells of animals (Peterson & Zettergren, 1970; Tanaka et al., 1977) and human tumour cells (Gasic et al., 1976) . We found that cultured human cancer cells had varied thromboplastic activity. From the results of coagulation studies using standard, Factor VIIdeficient and Factor IX-deficient human plasmas, the thromboplastic activity seems to be due to tissue thromboplastin of the tumour cells themselves. Thromboplastic activity of the cancer cells seems to be very important in terms of the pathophysiology of the patients with malignancy, such as thrombosis, non-bacterial thrombotic endocarditis (Rohner et al., 1966) and disseminated intravascular coagulation syndrome (Peck & Reiquam, 1973) . This activity is also considered to be closely related to fibrin deposition at the advancing border of tumours (Tanaka et al., 1977) and to the lodgement of circulating tumour cells in remote organs by tlhrombus formation (Kinjo, 1978 The cultured human cancer cells also showed varied fibrinolytic activity. The assay of this activity was based on the modified Astrup's method, using standard fibrin plates which were examined for evidence of plasminogen activator activity (Astrup & Kok, 1970) . Unkeless et al. (1973) adopted the method using isotopelabelled fibrin plates, and estimated the plasminogen-activator activity from the released radioactive material. Their method seemed to be very sensitive for evaluating plasminogen-activator activity. The main reasons why the modified Astrup's method was adopted were as follows. (1) The data obtained with modified Astrup's method were broadly accepted. (2) Experiments could be done with lower cost. Rifkin et al. (1974) found elevated levels of fibrinolysis independent of plasminogen and reported that this phenomenon was due to another type of protease. Nagy et al. (1977) also found a similar phenomenon in cultured human cancer cells, and they thought that there might be a plasminogen activator in residual blood among the cells. In the present study, we found no tumour cell lines producing plasmin or plasminogen independent protease. According to this experiment, 2 lines of squamous-cell carcinoma of the lung and one of adenosquamous carcinoma of the stomach showed high fibrinolytic activity. Peterson et al. (1975) showed a comparatively high fibrinolytic activity in 40-50% of bronchogenic carcinomas classified as epidermoid carcinoma or adenocarcinoma, but a comparatively low activity in most small cell anaplastic carcinoma. It is noteworthy to mention that their study did not exclude the stromal elements, which may have high fibrinolytic activity. Here, we found that 2 lines of high fibrinolytic activity were squamous cell carcinoma of the lung, while 6 lines of low fibrinolytic activity included 2 lines of anaplastic carcinoma and 3 lines of adenocarcinoma of the lung. No definite correlation was found between fibrinolytic activity and the histology of the original tumours.
In recent years the studies of Unkeless et al. (1973) and Ossowski et al. (1973) have been of particular interest. They have reported the appearance of plasminogen activator in cell cultures associated with oncogenic transformation, although Mott et al. (1974) and Wolf & Goldberg (1976) revealed lack of correlation in established cell lines. Rosenthal et al. (1977) and Nagy et al. (1977) showed that fibrinolytic activity Qf cancer cells was very varied, and that it was closely associated with the passage history of the cultured cells. Our present study also shows that plasminogenactivator production could be changed by the constituents of culture media, while thromboplastin production showed no such correlation. Some publications have appeared recently, describing an identity of plasminogen activator of the cultured human cancer cells with urokinase (Astedt & Holmberg, 1976; Wu et al., 1977) .
It is worth mentioning that plasminogen activator was found in the culture medium from tumour cells with high fibrinolytic activity and not in the culture medium of those with low fibrinolytic activity or none. Such a fact suggests the release of plasminogen activator from the tumour cells, as described by Bjorlin et al. (1972) .
